Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: A model of atopic dermatitis

Experimental Dermatology

Volumn 18, Issue 1, 2009, Pages 35-43

  Grimstad, Øystein ^a,b   Sawanobori, Yasushi ^c   Vestergaard, Christian ^d   Bilsborough, Janine ^e   Olsen, Uffe Bang ^f   Grønhøj Larsen, Christian ^a   Matsushima, Kouji ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF TOKYO   (Japan)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e Zymogenetics ^*  (United States)

^f NOVO NORDISK A S   (Denmark)

Author keywords

Dermatitis; Interleukin 31; NC Nga; Scratch

Indexed keywords

ALBUMIN; CYTOKINE; INTERLEUKIN 31; INTERLEUKIN 31 ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DISEASE SEVERITY; MALE; MOUSE; NONHUMAN; PRURITUS; SCRATCHING; SKIN DEFECT; WEIGHT GAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; BODY WEIGHT; DERMATITIS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKINS; MALE; MICE; PRURITUS; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN DISEASES;

EID: 57649243697     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00766.x     Document Type: Article

References (48)

1. Hanifin J M, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980: 92: 44-47.
2. Koblenzer C S. Itching and the atopic skin. J Allergy Clin Immunol 1999: 104(3Pt 2): S109-S113.
3. Stander S, Steinhoff M. Pathophysiology of pruritus in atopic dermatitis: An overview. Exp Dermatol 2002: 11: 12-24.
4. Finlay A Y. Quality of life in atopic dermatitis. J Am Acad Dermatol 2001: 45(Suppl. 1): S64-S66.
5. Greaves M W, Khalifa N. Itch: More than skin deep. Int Arch Allergy Immunol 2004: 135: 166-172.
6. Konishi H, Tsutsui H, Murakami T et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 2002: 99: 11340-11345.
7. Novak N, Bieber T, Leung D Y. Immune mechanisms leading to atopic dermatitis. J Allergy Clin Immunol 2003: 112(Suppl. 6): S128-S139.
8. Dillon S R, Sprecher C, Hammond A et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 2004: 5: 752-760.
9. Bilsborough J, Leung D Y, Maurer M et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 2006: 117: 418-425.
10. Suto H, Matsuda H, Mitsuishi K et al. NC/Nga mice: A mouse model for atopic dermatitis. Int Arch Allergy Immunol 1999: 120(Suppl. 1): 70-75.
11. Vestergaard C, Yoneyama H, Matsushima K. The NC/Nga mouse: A model for atopic dermatitis. Mol Med Today 2000: 6: 209-210.
12. Iijima O T, Takeda H, Komatsu Y, Matsumiya T, Takahashi H. Atopic dermatitis in NC/Jic mice associated with Myobia musculi infestation. Comp Med 2000: 50: 225-228.
13. Morita E, Kaneko S, Hiragun T et al. Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj. J Dermatol Sci 1999: 19: 37-43.
14. Tohda C, Yamaguchi T, Kuraishi Y. Increased expression of mRNA for myocyte-specific enhancer binding factor (MEF) 2C in the cerebral cortex of the itching mouse. Neurosci Res 1997: 29: 209-215.
15. Mihara K, Kuratani K, Matsui T, Nakamura M, Yokota K. Vital role of the itch-scratch response in development of spontaneous dermatitis in NC/Nga mice. Br J Dermatol 2004: 151: 335-345.
16. Hashimoto Y, Arai I, Takano N, Tanaka M, Nakaike S. Induction of scratching behaviour and dermatitis in various strains of mice cohabiting with NC/Nga mice with chronic dermatitis. Br J Dermatol 2006: 154: 28-33.
17. Yamaguchi T, Maekawa T, Nishikawa Y et al. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J Dermatol Sci 2001: 25: 20-28.
18. Takano N, Arai I, Kurachi M. A method to induce stable atopic dermatitis-like symptoms in NC/Nga mice housed with skin-lesioned mice. Br J Dermatol 2006: 154: 426-430.
19. Sonkoly E, Muller A, Lauerma A I et al. IL-31: A new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 2006: 117: 411-417.
20. Takaoka A, Arai I, Sugimoto M, Yamaguchi A, Tanaka M, Nakaike S. Expression of IL-31 gene transcripts in NC/Nga mice with atopic dermatitis. Eur J Pharmacol 2005: 516: 180-181.
21. Nickoloff B J, Stevens S R. What have we learned in dermatology from the biologic therapies?. J Am Acad Dermatol 2006: 54(3 Suppl. 2): S143-S151.
22. Maekawa T, Yamaguchi-Miyamoto T, Nojima H, Kuraishi Y. Effects of naltrexone on spontaneous itch-associated responses in NC mice with chronic dermatitis. Jpn J Pharmacol 2002: 90: 193-196.
23. Takano N, Arai I, Kurachi M. Analysis of the spontaneous scratching behavior by NC/Nga mice: A possible approach to evaluate antipruritics for subjects with atopic dermatitis. Eur J Pharmacol 2003: 471: 223-228.
24. Inagaki N, Igeta K, Kim J F et al. Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80. Eur J Pharmacol 2002: 448: 175-183.
25. Inagaki N, Igeta K, Shiraishi N et al. Evaluation and characterization of mouse scratching behavior by a new apparatus, MicroAct. Skin Pharmacol Appl Skin Physiol 2003: 16: 165-175.
26. Hashimoto Y, Arai I, Nakanishi Y, Sakurai T, Nakamura A, Nakaike S. Scratching of their skin by NC/Nga mice leads to development of dermatitis. Life Sci 2004: 76: 783-794.
27. Takaoka A, Arai I, Sugimoto M et al. Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol 2006: 15: 161-167.
28. Takahashi N, Arai I, Honma Y et al. Scratching behavior in spontaneous - or allergic contact-induced dermatitis in NC/Nga mice. Exp Dermatol 2005: 14: 830-837.
29. Koblenzer C S, Koblenzer P J. Chronic intractable atopic eczema. Its occurrence as a physical sign of impaired parent-child relationships and psychologic developmental arrest: Improvement through parent insight and education. Arch Dermatol 1988: 124: 1673-1677.
30. Meyer R A, Campbell J N, Raja S N et al. Peripheral neural mechanisms of nociception. In: Wall P D & R Melzack (eds). Textbook of Pain, 3rd edn. Edinburgh: Churchill Livingstone, 1994: 13-15.
31. Takano N, Sakurai T, Kurachi M. Effects of anti-nerve growth factor antibody on symptoms in the NC/Nga mouse, an atopic dermatitis model. J Pharmacol Sci 2005: 99: 277-286.
32. Stante M, Hanna D, Lotti T. Itch, pain, and metaesthetic sensation. Dermatol Ther 2005: 18: 308-313.
33. Bando T, Morikawa Y, Komori T, Senba E. Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns. Neuroscience 2006: 142: 1263-1271.
34. Pendley C, Schantz A, Wagner C. Immunogenicity of therapeutic monoclonal antibodies. Curr Opin Mol Ther 2003: 5: 172-179.
35. Schellekens H. Factors influencing the immunogenicity of therapeutic proteinsV Nephrol Dial Transplant 2005: 20(Suppl. 6): vi3-vi9.
36. Matsuda H, Watanabe N, Geba G P et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 1997: 9: 461-466.
37. Laltoo H, Van Zoost T, Kind L S. IgE antibody response to mite antigens in mite infested mice. Immunol Commun 1979: 8: 1-9.
38. Yamamoto M, Haruna T, Yasui K et al. A novel atopic dermatitis model induced by topical application with dermatophagoides farinae extract in NC/Nga mice. Allergol Int 2007: 56: 139-148.
39. Vestergaard C, Yoneyama H, Murai M et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 1999: 104: 1097-1105.
40. Kakinuma T, Nakamura K, Wakugawa M et al. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 2001: 107: 535-541.
41. Kakinuma T, Nakamura K, Wakugawa M et al. Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis. Clin Exp Immunol 2002: 127: 270-273.
42. Gombert M, Dieu-Nosjean M C, Winterberg F et al. CCL1-CCR8 interactions: an axis mediating the recruitment of T cells and Langerhans-type dendritic cells to sites of atopic skin inflammation. J Immunol 2005: 174: 5082-5091.
43. Perrigoue J G, Li J, Zaph C et al. IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med 2007: 204: 481-487.
44. Habu Y, Seki S, Takayama E et al. The mechanism of a defective IFN-gamma response to bacterial toxins in an atopic dermatitis model, NC/Nga mice, and the therapeutic effect of IFN-gamma, IL-12, or IL-18 on dermatitis. J Immunol 2001: 166: 5439-5447.
45. Horiuchi Y, Bae S, Katayama I, Oshikawa T, Okamoto M, Sato M. Lipoteichoic acid-related molecule derived from the streptococcal preparation, OK-432, which suppresses atopic dermatitis-like lesions in NC/Nga mice. Arch Dermatol Res 2006: 298: 163-173.
46. Horiuchi Y, Bae S, Katayama I, Nishioka K. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/ Nga mice: Possible shift from a Th2- to Th1-predominance. J Dermatol Sci 2004: 35: 187-197.
47. Terada M, Tsutsui H, Imai Y et al. Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci USA 2006: 103: 8816-8821.
48. Yagi R, Nagai H, Iigo Y, Akimoto T, Arai T, Kubo M. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002: 168: 2020-2027.